SeaSpine signs definitive agreement to acquire NLT Spine


SeaSpine has entered into a definitive agreement to acquire all assets of NLT Spine, an Israel-based medical device company developing spinal products for minimally invasive surgery.

NLT’s platforms include vertical, lordotic and footprint expanding interbody technologies for use in lumbar fusion procedures for the treatment of degenerative spinal conditions.  By allowing surgeons to place smaller interbody implants that expand within the interbody space, these patented technologies are designed to enable smaller incisions and less nerve retraction, while achieving the same advantages of larger implants, with easier insertion and potentially less tissue disruption.

Acquisition terms include an upfront cash payment, issuance of common stock upon achievement of a near-term regulatory milestone, longer-term commercially-based milestone payments, as well as future revenue-based royalties.